Vaxxinity Statistics
Total Valuation
Vaxxinity has a market cap or net worth of 2.53 million. The enterprise value is -12.93 million.
| Market Cap | 2.53M |
| Enterprise Value | -12.93M |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Vaxxinity has 126.75 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Shares Outstanding | 126.75M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 9.11% |
| Owned by Institutions (%) | 0.22% |
| Float | 55.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.23 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.22 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 113.12.
| Current Ratio | 1.89 |
| Quick Ratio | 1.76 |
| Debt / Equity | 113.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.26 |
| Interest Coverage | -83.74 |
Financial Efficiency
Return on equity (ROE) is -150.65% and return on invested capital (ROIC) is -69.19%.
| Return on Equity (ROE) | -150.65% |
| Return on Assets (ROA) | -48.34% |
| Return on Capital (ROIC) | -69.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -933,344 |
| Employee Count | 65 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.62% in the last 52 weeks. The beta is 3.05, so Vaxxinity's price volatility has been higher than the market average.
| Beta (5Y) | 3.05 |
| 52-Week Price Change | -93.62% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.38 |
| Relative Strength Index (RSI) | 45.77 |
| Average Volume (20 Days) | 9,191 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -58.29M |
| Pretax Income | -56.93M |
| Net Income | -56.93M |
| EBITDA | -56.05M |
| EBIT | -58.29M |
| Earnings Per Share (EPS) | -0.45 |
Balance Sheet
The company has 30.64 million in cash and 15.17 million in debt, giving a net cash position of 15.47 million or 0.12 per share.
| Cash & Cash Equivalents | 30.64M |
| Total Debt | 15.17M |
| Net Cash | 15.47M |
| Net Cash Per Share | 0.12 |
| Equity (Book Value) | 13.41M |
| Book Value Per Share | 0.11 |
| Working Capital | 15.63M |
Cash Flow
In the last 12 months, operating cash flow was -57.24 million and capital expenditures -803,000, giving a free cash flow of -58.04 million.
| Operating Cash Flow | -57.24M |
| Capital Expenditures | -803,000 |
| Free Cash Flow | -58.04M |
| FCF Per Share | -0.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Vaxxinity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.45% |
| Shareholder Yield | -0.45% |
| Earnings Yield | -2,250.20% |
| FCF Yield | -2,289.63% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |